Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 1.3% |
 |
Gilead SciencesGILD |
57 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 78 | |
| Sep 2024 | 80 | |
| Aug 2024 | 82 | |
| Jul 2024 | 82 | |
| Jun 2024 | 81 |
How do employees feel about the future at Regeneron?
The Business Outlook at Regeneron is positive according to its employees. The average outlook rating 79 (out of 100) is high. This rating, aggregated from the top review sites in the US, is also up by 1.3% since the last month.
Analyzing Business Outlook, how is Regeneron performing compared to its industry peers?
Regeneron overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 79th percentile.
How has the business outlook at Regeneron changed over the last couple of months
In recent months, Regeneron's employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Regeneron?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Regeneron.
